Literature DB >> 19217135

The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines.

Zachary L Pratt1, Malika Kuzembayeva, Srikumar Sengupta, Bill Sugden.   

Abstract

Epstein-Barr Virus (EBV) encodes multiple microRNAs (miRNAs) from two primary transcripts, BHRF1 and the BARTs. The expression of BHRF1 miRNAs is dependent on the type of viral latency, whereas the BART miRNAs are expressed in cells during all forms of latency. It is not known how these miRNAs are otherwise regulated, though. We have used quantitative, stem-loop, real-time PCR to measure the expression of EBV's miRNAs and found them to differ nearly 50- and 25-fold among all tested cell lines and among EBV-positive Burkitt's lymphomas, respectively. In addition, the expression of individual BART miRNAs within a cell can differ by 50-fold or more despite the fact these miRNAs are likely transcribed together as a single primary transcript. These measurements are illuminating: they indicate that few of EBV's miRNAs are expressed at levels comparable to those of cellular miRNAs in most cell lines and therefore likely function interdependently.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217135      PMCID: PMC2763627          DOI: 10.1016/j.virol.2009.01.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  52 in total

1.  The microRNA Registry.

Authors:  Sam Griffiths-Jones
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  Mfold web server for nucleic acid folding and hybridization prediction.

Authors:  Michael Zuker
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

3.  Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.

Authors:  Stefan Costinean; Nicola Zanesi; Yuri Pekarsky; Esmerina Tili; Stefano Volinia; Nyla Heerema; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

4.  Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.

Authors:  Maria Leao; Emma Anderton; Mark Wade; Kiran Meekings; Martin J Allday
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

5.  Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction.

Authors:  N Kitagawa; M Goto; K Kurozumi; S Maruo; M Fukayama; T Naoe; M Yasukawa; K Hino; T Suzuki; S Todo; K Takada
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

6.  Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma.

Authors:  Asuka Nanbo; Kaori Inoue; Kumi Adachi-Takasawa; Kenzo Takada
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

7.  Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma.

Authors:  Do Nyun Kim; Hiun-Suk Chae; Sang Taek Oh; Jin-Hyoung Kang; Cho Hyun Park; Won Sang Park; Kenzo Takada; Jae Myun Lee; Won-Keun Lee; Suk Kyeong Lee
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.

Authors:  Gemma Kelly; Andrew Bell; Alan Rickinson
Journal:  Nat Med       Date:  2002-09-03       Impact factor: 53.440

9.  Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer.

Authors:  J Huang; H Chen; L Hutt-Fletcher; R F Ambinder; S D Hayward
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer.

Authors:  Sang-Uk Han; Heung-Tae Kim; Do Hwan Seong; Yong-Suk Kim; Yoon-Soo Park; Yung-Jue Bang; Han-Kwang Yang; Seong-Jin Kim
Journal:  Oncogene       Date:  2004-02-19       Impact factor: 9.867

View more
  73 in total

Review 1.  The role of microRNAs in Epstein-Barr virus latency and lytic reactivation.

Authors:  Eleonora Forte; Micah A Luftig
Journal:  Microbes Infect       Date:  2011-07-28       Impact factor: 2.700

Review 2.  EBV Noncoding RNAs.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

3.  The members of an Epstein-Barr virus microRNA cluster cooperate to transform B lymphocytes.

Authors:  Regina Feederle; Janina Haar; Katharina Bernhardt; Sarah D Linnstaedt; Helmut Bannert; Helge Lips; Bryan R Cullen; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 4.  Viral miRNAs and immune evasion.

Authors:  Isaac W Boss; Rolf Renne
Journal:  Biochim Biophys Acta       Date:  2011-07-05

5.  Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells.

Authors:  Asuka Nanbo; Eri Kawanishi; Ryuji Yoshida; Hironori Yoshiyama
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

6.  The Epstein-Barr virus microRNA BART11-5p targets the early B-cell transcription factor EBF1.

Authors:  Nathan Ross; Maher K Gandhi; Jamie P Nourse
Journal:  Am J Blood Res       Date:  2013-08-19

7.  The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines.

Authors:  Do Nyun Kim; Yoon Jae Song; Suk Kyeong Lee
Journal:  Exp Mol Med       Date:  2011-07-30       Impact factor: 8.718

Review 8.  Viruses and microRNAs: RISCy interactions with serious consequences.

Authors:  Bryan R Cullen
Journal:  Genes Dev       Date:  2011-09-06       Impact factor: 11.361

Review 9.  Multiple functions are mediated by the miRNAs of Epstein-Barr virus.

Authors:  Malika Kuzembayeva; Mitchell Hayes; Bill Sugden
Journal:  Curr Opin Virol       Date:  2014-05-10       Impact factor: 7.090

10.  Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome.

Authors:  Roland Hutzinger; Regina Feederle; Jan Mrazek; Natalia Schiefermeier; Piotr J Balwierz; Mihaela Zavolan; Norbert Polacek; Henri-Jacques Delecluse; Alexander Hüttenhofer
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.